Health-Related Quality of Life (HRQoL) Among Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1: Interim Assessment up to 36 Weeks of TreatmentJames E. Hoffman,Naresh Bumma,Joshua Richter,Madhav V. Dhodapkar,Hans C. Lee,Attaya Suvannasankha, Christiane A. Houde,Joseph J. Maly,Mansi R. Shah,Rachid Baz,Swathi Namburi,Ka Lung Wu,Matthew Pianko,Jing Christine Ye,Suzanne Lentzsch,Rebecca Silbermann,Chang-Ki Min,Marie-Christiane Vekemans,Markus Munder,Ja Min Byun,Joaquin Martinez Lopez,Michelle DeVeaux,Cristina Ivanescu, Karen Rodriguez Lorenc,Glenn S. Kroog,Yariv Houvras, Timothy J. Inocencio,Lei Chi,James Harnett,Qiufei Ma, Sundar JagannathBLOOD(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要